Is BMNDF or MRK a better dividend investment in 2026?

BMNDF currently yields 18181.82% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: BMNDF offers higher current income.

What is the dividend yield difference between BMNDF and MRK?

BMNDF has a forward dividend yield of 18181.82% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 18179.06 percentage points.

Home › Compare › BMNDF vs MRK

BMNDF vs MRK: Dividend Comparison 2026

BMNDF yields 18181.82% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BMNDF wins by $658834.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BMNDF

● Live price

18181.82%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$658834.86M

Annual income

$54,543,841,013.90

Full BMNDF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — BMNDF vs MRK

📍 BMNDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BMNDF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BMNDF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BMNDF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMNDF

Annual income on $10K today (after 15% tax)

$1,545,454.55/yr

After 10yr DRIP, annual income (after tax)

$46,362,264,861.82/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, BMNDF beats the other by $46,362,256,533.40/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMNDF + MRK for your $10,000?

BMNDF: 50%MRK: 50%

100% MRK50/50100% BMNDF

Portfolio after 10yr

$329417.46M

Annual income

$27,271,925,406.02/yr

Blended yield

8.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BMNDF

No analyst data

Altman Z

-414.3

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMNDF buys

MRK buys

No recent congressional trades found for BMNDF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBMNDFMRK

Forward yield	18181.82% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	32.7% ✓
Portfolio after 10y	$658834.86M ✓	$56.8K
Annual income after 10y	$54,543,841,013.90 ✓	$9,798.13
Total dividends collected	$553757.55M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BMNDF vs MRK ($10,000, DRIP)

Year	BMNDF Portfolio	BMNDF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$919,791	$909,090.91	$11,206	$366.19	+$908.6K → BMNDF
2	$40,057,707	$39,073,530.55	$12,650	$502.35	+$40.05M → BMNDF
3	$838,042,485	$795,180,738.70	$14,407	$694.19	+$838.03M → BMNDF
4	$8,670,481,609	$7,773,776,150.53	$16,585	$967.82	+$8670.47M → BMNDF
5	$46,860,761,379	$37,583,346,056.88	$19,342	$1,363.89	+$46860.74M → BMNDF
6	$145,058,842,015	$94,917,827,338.98	$22,913	$1,947.19	+$145058.82M → BMNDF
7	$292,512,437,337	$137,299,476,380.97	$27,662	$2,823.89	+$292512.41M → BMNDF
8	$442,364,760,258	$129,376,452,307.77	$34,159	$4,173.35	+$442364.73M → BMNDF
9	$564,757,963,223	$91,427,669,747.44	$43,337	$6,308.80	+$564757.92M → BMNDF
10	$658,834,861,663	$54,543,841,013.90	$56,776	$9,798.13	+$658834.80M → BMNDF

BMNDF vs MRK: Complete Analysis 2026

BMNDF — Stock

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammation, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.

Full BMNDF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this BMNDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMNDF vs SCHD BMNDF vs JEPI BMNDF vs O BMNDF vs KO BMNDF vs MAIN BMNDF vs JNJ BMNDF vs ABBV BMNDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.